Autoantibodies targeting TRIM72 compromise membrane repair and contribute to inflammatory myopathy.
McElhanon KE, Young N, Hampton J, Paleo BJ, Kwiatkowski TA, Beck EX, Capati A, Jablonski K, Gurney T, Perez MAL, Aggarwal R, Oddis CV, Jarjour WN, Weisleder N.
McElhanon KE, et al. Among authors: beck ex.
J Clin Invest. 2020 Aug 3;130(8):4440-4455. doi: 10.1172/JCI131721.
J Clin Invest. 2020.
PMID: 32687067
Free PMC article.